Pivmecillinam for the treatment of acute uncomplicated urinary infection

International Journal of Clinical Practice

Volumn 53, Issue 8, 1999, Pages 612-617

  Nicolle, Lindsay E ^a  

^a HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; COTRIMOXAZOLE; NALIDIXIC ACID; PIVMECILLINAM; SULFADIAZINE; SULFAMETHOXAZOLE; SULFONAMIDE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; CYSTITIS; DRUG EFFICACY; DRUG SAFETY; ESCHERICHIA COLI; GASTROINTESTINAL SYMPTOM; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RASH; REVIEW; SCANDINAVIA; URINARY TRACT INFECTION; VAGINA CANDIDIASIS;

ACUTE DISEASE; AMDINOCILLIN PIVOXIL; CLINICAL TRIALS; FEMALE; HUMANS; PENICILLINS; URINARY TRACT INFECTIONS;

EID: 0033374918     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Neu HC. Amdinocillin: a novel penicillin. Antibacterial activity, pharmacology and clinical use. Pharmacotherapy 1985; 5: 1-10.
2. Roholt K, Nielsen B, Kristensen E. Pharmacokinetic studies with mecillinam and pivmecillinam. Chemotherapy 1975; 21: 146-166.
3. Josefson K, Bergan T, Magni L et al. Pharmacokinetics of bacmecillinam and pivmecillinam in volunteers. Eur J Clin Pharmacol 1982; 23: 249-252.
4. Anderson JD, Adams MA. Urinary excretion of mecillinam by volunteers receiving film-coated tablets of pivmecillinam hydrochloride. Chemotherapy 1979; 25: 1-4.
5. Anderson JD, Adams MA, Barrington JC et al. Comparison of the epidemiology of bacterial resistance to mecillinam and ampicillin. Antimicrob Agents Chemother 1976; 10: 872-877.
6. Cars O, Sandberg T. Observanda. Begränsa användningen av fluorokinoloner vid UVI. Information Från Läkemedelsverket 1996; 2(1): 3-4.
7. Ikaheimo R, Siitonen A, Heiskanen T et al. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis 1996; 22: 91-99.
8. Hooton, TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clins North Am 1997; 11: 551-581.
9. Carlson, KJ, Mulley, AG. Management of acute dysuria: a decision-analysis model of alternative strategies. Ann Intern Med 1985; 102: 244-249.
10. Beunders, AJ. Development of antibacterial resistance: the Dutch experience. J Antimicrob Chemother 1994; 33(suppl A): 17-22.
11. Gruneberg, RN. Changes in urinary pathogens and their antibiotic sensitivities 1971-1972. J Antimicrob Chemother 1994; 33(suppl A): 1-8.
12. Nicolle, LE. Measurement and significance of antibiotic activity in the urine. In Lorian V, Ed. Antibiotics in laboratory medicine, 4th edn. Baltimore: Williams and Wilkins, 1996: 793-812.
13. Saginur R, Nicolle, LE, Canadian Clinical Trials Study Group. Single-dose compared with 3-day norfloxacin treatment of uncomplicated urinary tract infections in women. Arch Intern Med 1992; 152: 1233-1237.
14. Fihn SD, Johnson C, Roberts PL et al. Trimethoprim-sulfamethoxazole for acute dysuria in women: a single-dose or 10-day course. Ann Intern Med 1988; 108: 350-357.
15. Vorland LH, Carlson K, Aalen O. Antibiotic resistance and small R plasmids among Escherichia coli isolates from outpatient urinary tract infections in northern Norway. Antimicrob Agents Chemother 1985; 27: 107-113.
16. de Mouy D, Auriol JC, de Cleriq G et al. The frequency of isolating urinary infection germs at a community practice and their sensitivity to various antibiotics. Pathologic Biologie 1988; 36: 1011-1015.
17. Vizcaino ME, Garcia JF, Sanchez-Robles LC et al. Urinary tract infections in primary care: predominant microbes and their antibiotic sensitivity. Atencion Primaria 1989; 6: 165-168.
18. Hannan M, Cormican M, Flynn J. A comparison of antimicrobial sensitivities of urinary pathogens. Ir J Med Sci 1993; 162: 499-501.
19. Maartens G, Oliver SP. Antibiotic resistance in community-acquired urinary tract infection. S Afr Med J 1994; 84: 600-602.
20. Mazzulli T, Skulnick M, Small G et al. Continued susceptibility of community gram negative urinary tract isolates to mecillinam and other oral agents. In: Program and Abstracts of the Thirty-Eighth Conference on Antimicrobial Agents and Chemotherapy, San Diego CA, 1998. Abstract American Society for Microbiology, Washington, DC.
21. Alon U, Davidai G, Berant M et al. Five year survey of changing patterns of susceptibility of bacterial uropathogens to trimethoprim-sulfamethoxazole and other antimicrobial agents. Antimicrob Agents Chemother 1987; 31: 126-128.
22. Ansbach RK, Dybus KR, Bergeson R. Uncomplicated E. coli urinary tract infection in college women: a retrospective study of E. coli sensitivities to commonly prescribed antibiotics. College Health 1995; 43: 183-185.
23. Piddock LJV. Fluoroquinolone resistance. BMJ 1998; 317; 1029-1030.
24. Maria RI, Gonzalez RG, Gamez JCV et al. Etiología y resistencia bacteriana de las infecciones urinarias extrahospitalarias. Semergen 1999; 25(1): 11-14.
25. Esko E, Renkonen OV. Comparative in vitro activity of norfloxacin and seven other antimicrobial agents against clinical isolates from urinary tract infections. Scand J Infect Dis 1985; 17: 95-98.
26. Henning C, Bengtsson L. Behandling av akuta urinvägsbesvär. Läkartidningen 1997; 94(25): 2387-2390.
27. Skinner JL, Venables TL, Sheldon MG. A general practice evaluation of pivmecillinam given twice daily as a treatment for acute urinary tract infection. Pharmatherapeutica 1984; 4: 25-31.
28. Sutlieff PA. A comparison between a 3-day and a 5-day course of pivmecillinam as a treatment for acute lower urinary tract infections in general practice. Curr Med Res Opin 1982; 7: 563-568.
29. Hansen PH, Kristensen KH, Ericksen HAL et al. Pivmecillinam in acute cystitis: a comparison of three and seven days treatment. J Drug Res 1980; 5: 758-761.
30. Bitsch M, Hansen PH, Pagh J. Treatment of acute cystitis: a comparison of a three day course of pivmecillinam and a six day course of sulfamethizole. J Drug Ther Res 1984; 9: 26-28.
31. Donald JF, Rimmer DMD. An open evaluation of a 3-day course of pivmecillinam in women with acute uncomplicated cystitis. J Intern Med Res 1980; 8: 112-117.
32. Gordin A, Kalema S, Makela P et al. Comparison of three-and ten day regimens with a sulfadiazine-trimethoprim combination and pivmecillinam in acute lower urinary tract infections. Scand J Infect Dis 1987; 19: 97-102.
33. Marsh BT, Menday AP. Comparative efficacy of 3-day and 7-day chemotherapy with pivmecillinam in urinary tract infections in general practice. J Intern Med Res 1980; 8: 105-111.
34. Pitkäjärvi T, Pyykonen M-L, Kannisto K et al. Pivmecillinam treatment in acute cystitis: three versus seven days study. Drug Res 1990; 40: 1156-1158.
35. Place C. An open, multi-centre evaluation of a 5-day course of pivmecillinam in urinary tract infections in general practice. Pharmatherapeutica 1981; 3: 55-60.
36. Richards HH. Comparative efficacy of 3-day and 7-day chemotherapy with twice-daily pivmecillinam in urinary tract infections seen in general practice. Curr Med Res Opin 1984; 9: 197-203.
37. Hovelius B, Mardh PA, Nygaard-Pederson L et al. Nalidixic acid and pivmecillinam for treatment of acute lower urinary tract infections. Scand J Prim Care 1985; 3: 227-232.
38. Peddie BA, Little PJ. Pivmecillinam in uncomplicated urinary tract infections in general practice. NZ Med J 1981; 93: 109-111.
39. Guttman D. A comparison of pivmecillinam and cotrimoxazole in the treatment of simple cystitis in general practice. J Antimicrob Chemother 1977; 3(suppl B): 137-140.
40. Granlund M, Landgren E. Henning C. Pivmecillinam in treatment of Staphylococcus saprophyticus urinary tract infections. Scand J Infect Dis 1983; 15: 65-69.
41. Patterson TF, Andriole VT. Detection, significance, and therapy of bacteriuria in pregnancy: update in the managed health care era. Infect Dis Clins North Am 1997; 11: 593-608.
42. Brumfitt W. Franklin I, Hamilton-Miller J et al. Comparison of pivmecillinam and cephradine in bacteriuria in pregnancy and in acute urinary tract infection. Scand J Infect Dis 1979; 11: 275-279.
43. Bint A, Bullock D, Reeves D et al. A comparative trial of pivmecillinam and ampicillin in bacteriuria in pregnancy. Infection 1979; 7: 290-293.
44. Sanderson P, Menday P. Pivmecillinam for bacteriuria in pregnancy. J Antimicrob Chemother 1984; 13: 383-388.
45. Heikkila AM. Antibiotics in pregnancy: a prospective cohort study on the policy of antibiotic prescription. Ann Med 1993; 25: 467-471.
46. Jodal U, Larsson P, Hansson S et al. Pivmecillinam in long-term prophylaxis to girls with recurrent urinary tract infection. Scand J Infect Dis 1989; 21: 299-302.
47. Moller JK, Stendereys A. The influence of long-term treatment with mecillinam on fecal Escherichia coli. Scand J Infect Dis 1984; 16: 223-224.